Skip to main content

Dr. Chow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chow's full profile

Already have an account?

  • Office

    700 Lawrence Expy
    Santa Clara, CA 95051
    Phone+1 408-851-1000
    Fax+1 510-625-6226

Education & Training

  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Emergency Medicine, 2005 - 2008
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterInternship, Transitional Year, 2004 - 2005
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • American Board of Emergency Medicine Emergency Medicine

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Press Mentions

  • Diroximel Fumarate (DRF) in Patients with Relapsing–Remitting Multiple Sclerosis: Interim Safety and Efficacy Results from the Phase 3 EVOLVE-MS-1 Study
    Diroximel Fumarate (DRF) in Patients with Relapsing–Remitting Multiple Sclerosis: Interim Safety and Efficacy Results from the Phase 3 EVOLVE-MS-1 StudyNovember 4th, 2019
  • Safety and Efficacy of Daclizumab Beta in Patients with Relapsing Multiple Sclerosis in a 5-Year Open-Label Study (EXTEND): Final Results Following Early Termination
    Safety and Efficacy of Daclizumab Beta in Patients with Relapsing Multiple Sclerosis in a 5-Year Open-Label Study (EXTEND): Final Results Following Early TerminationMarch 23rd, 2021